MAPT and Alzheimer disease: Mouse neurodegenerative datasets (n = 9) included ALS (various SOD1 mutants, n = 3) [16–18] and AD models of both brain β-amyloidosis (n = 5) (APPswe/PSEN1deltaE9 n = 3 and PS2APP n = 2) [19–23], and tauopathy (P301S-MAPT, n = 1) [23].